ISPOR Launches HEOR News Desk

Published Oct 18, 2022

New Microsite Covers Global Health Economics and Outcomes Research News

HEOR News DeskLawrenceville, NJ, USA—October 18, 2022—ISPOR—The Professional Society for Health Economics and Outcomes Research announced today that it has launched its HEOR News Desk, a new offering that selects and aggregates global news related to health economics and outcomes research (HEOR).

Interest in the field of HEOR has been growing exponentially as governments and other payers grapple with how to provide the best possible health outcomes at affordable costs. Global healthcare trends have accelerated the demand for data-driven healthcare decisions, making the need for HEOR ever more important.

ISPOR’s HEOR News Desk is designed to serve as a source of selected HEOR-related news from around the world that is of interest to anyone with an interest in HEOR. The HEOR News Desk is freely accessible to all—both ISPOR members and nonmembers. The Society also offers a complimentary subscription to its HEOR News Brief that distributes news stories from the HEOR News Desk.

Additional information can be found at:

                HEOR News Desk

                Subscribe to HEOR News

                ISPOR News


ISPOR—The Professional Society for Health Economics and Outcomes Research (HEOR), is an international, multistakeholder, nonprofit dedicated to advancing HEOR excellence to improve decision making for health globally. The Society is the leading source for scientific conferences, peer-reviewed and MEDLINE®-indexed publications, good practices guidance, education, collaboration, and tools/resources in the field.
Website  | LinkedIn  | Twitter (@ispororg)  |  YouTube  |  Facebook  |  Instagram 

Related Stories

Global Experts Highlight Concerns With Implementation of IRA-Mandated Medicare Drug Price Negotiation Program

Dec 5, 2023

Value in Health announced the publication of 2 new commentaries by leading experts in health economics and outcomes research, both of which raise important questions as the Centers for Medicare & Medicaid Services move forward to implement the Inflation Reduction Act’s Medicare Drug Price Negotiation Program.

Medicare Could Save an Additional $10 Billion Annually Across 10 Drugs by Using a Therapeutic Reference Pricing Approach in Upcoming Price Negotiations

Nov 7, 2023

Value in Health announced the publication of a study showing that United States Medicare could save up to an additional $5-$10 billion dollars annually across 10 drugs if it negotiated prices using a therapeutic reference pricing approach rather than using the statutory ceiling price alone.

Global Medical Device Panel Finds Little Evidence Linking Health Technology Assessment Processes to Medical Device Purchasing Decisions

Nov 6, 2023

Value in Health, the official journal of ISPOR, announced the publication of the results of a systematic literature review showing that there is sparce evidence in the health research literature to link health technology assessment processes and outcomes with device purchasing decisions
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on Update my browser now